{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:32:48Z","timestamp":1778027568901,"version":"3.51.4"},"reference-count":78,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"DOI":"10.1210\/jc.2007-1549","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T18:43:22Z","timestamp":1196793802000},"page":"4546-4556","source":"Crossref","is-referenced-by-count":255,"title":["POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome\u2014A Position Statement of the Androgen Excess Society"],"prefix":"10.1210","volume":"92","author":[{"given":"Kelsey E. S.","family":"Salley","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, and Departments of Internal Medicine (K.E.S.S., E.P.W., P.A.E., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond P.","family":"Wickham","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics (E.P.W., N.W.K.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"},{"name":"Division of Endocrinology and Metabolism, and Departments of Internal Medicine (K.E.S.S., E.P.W., P.A.E., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai I.","family":"Cheang","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy (K.I.C.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina A.","family":"Essah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, and Departments of Internal Medicine (K.E.S.S., E.P.W., P.A.E., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole W.","family":"Karjane","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (N.W.K., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"},{"name":"Departments of Pediatrics (E.P.W., N.W.K.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Nestler","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (N.W.K., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"},{"name":"Division of Endocrinology and Metabolism, and Departments of Internal Medicine (K.E.S.S., E.P.W., P.A.E., J.E.N.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0111"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113513307800_R1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R4","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R5","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Androgen Excess Society 2006 Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.","volume":"91","author":"Azziz","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113513307800_R7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113513307800_R9","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","article-title":"Standards of medical care in diabetes\u20132007","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R11","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R12","first-page":"833","article-title":"Prevalence of diabetes and impaired fasting glucose in adults\u2013United States, 1999\u20132000.","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2019041113513307800_R13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R14","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/del142","article-title":"Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113513307800_R15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0020-7292(01)00477-5","article-title":"Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome.","volume":"75","author":"Weerakiet","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113513307800_R16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000181560","article-title":"Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS)","volume":"33","author":"Kinoshita","year":"1990","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113513307800_R17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00404-006-0241-0","article-title":"Glucose intolerance in Japanese patients with polycystic ovary syndrome.","volume":"275","author":"Kurioka","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t2019041113513307800_R18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0015-0282(16)57297-5","article-title":"Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome.","volume":"63","author":"Norman","year":"1995","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113513307800_R19","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113513307800_R20","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0029-7844(98)00133-1","article-title":"Polycystic ovaries in women with gestational diabetes.","volume":"92","author":"Anttila","year":"1998","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113513307800_R22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.","volume":"83","author":"Holte","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113513307800_R24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/dc06-0877","article-title":"Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study.","volume":"29","author":"Lo","year":"2006","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113513307800_R26","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","article-title":"A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance.","volume":"51","author":"Ek","year":"2002","journal-title":"Diabetes"},{"issue":"2 Pt 1","key":"key\n\t\t\t\t2019041113513307800_R28","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113513307800_R29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1210\/jc.2003-030437","article-title":"Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.","volume":"89","author":"Baillargeon","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diacare.29.02.06.dc05-1070","article-title":"Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.","volume":"29","author":"Baillargeon","year":"2006","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113513307800_R32","first-page":"942","article-title":"\u03b2-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"key\n\t\t\t\t2019041113513307800_R33","first-page":"1299","article-title":"Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic \u03b2-cell","volume":"13","author":"Ehrmann","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/jc.2004-1006","article-title":"\u03b2-Cell function: a key pathological determinant in polycystic ovary syndrome.","volume":"90","author":"Goodarzi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R35","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease.","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.2004-0229","article-title":"Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.","volume":"90","author":"Ehrmann","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.0001-6349.2005.00627.x","article-title":"Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome.","volume":"84","author":"Trolle","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t2019041113513307800_R38","first-page":"2591","article-title":"Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.","volume":"86","author":"Koivunen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R39","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00125-006-0395-0","article-title":"Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.","volume":"49","author":"Mohlig","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113513307800_R40","year":"2006"},{"key":"key\n\t\t\t\t2019041113513307800_R41","year":"1985"},{"key":"key\n\t\t\t\t2019041113513307800_R42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t2019041113513307800_R43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(05)60263-2","article-title":"A low carbohydrate intake before oral glucose-tolerance tests","volume":"352","author":"Kaneko","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113513307800_R44","first-page":"857","author":"Nestler","year":"2006"},{"key":"key\n\t\t\t\t2019041113513307800_R45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bmj.317.7155.371","article-title":"Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113513307800_R46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/diacare.21.8.1236","article-title":"Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study.","volume":"21","author":"Barrett-Connor","year":"1998","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diacare.23.8.1108","article-title":"The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.","volume":"23","author":"Gabir","year":"2000","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2796.2004.01336.x","article-title":"High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius.","volume":"256","author":"Soderberg","year":"2004","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041113513307800_R50","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113513307800_R51","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R52","first-page":"393","article-title":"Diabetes Prevention Program Research Group 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113513307800_R53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Finnish Diabetes Prevention Study Group 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.","volume":"344","author":"Tuomilehto","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113513307800_R54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113513307800_R56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1479-828X.1999.tb03363.x","article-title":"A trial of simple versus intensified dietary modification for prevention of progression to diabetes mellitus in women with impaired glucose tolerance.","volume":"39","author":"Wein","year":"1999","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041113513307800_R57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.21.3.350","article-title":"Lifestyle intervention in overweight individuals with a family history of diabetes.","volume":"21","author":"Wing","year":"1998","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1462-8902.2004.0348.x","article-title":"Thiazolidinedione therapy in the prevention\/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance.","volume":"6","author":"Durbin","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113513307800_R60","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113513307800_R61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archinte.160.9.1321","article-title":"Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.","volume":"160","author":"Heymsfield","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113513307800_R62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R63","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diacare.26.4.977","article-title":"Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.","volume":"26","author":"Diabetes Prevention Program Research Group","year":"2003","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R64","first-page":"1150","article-title":"Diabetes Prevention Program Research Group 2005 Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.","volume":"54","author":"Knowler","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113513307800_R65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2265.1999.00786.x","article-title":"The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"51","author":"Unluhizarci","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113513307800_R66","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance.","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj.52.299","article-title":"Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease.","volume":"52","author":"Dereli","year":"2005","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113513307800_R68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.beem.2006.02.003","article-title":"Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.","volume":"20","author":"Sharma","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R69","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes.","volume":"355","author":"The DREAM Trial Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113513307800_R70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t2019041113513307800_R71","first-page":"3251","article-title":"Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.","volume":"85","author":"Ibanez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R72","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.","volume":"88","author":"Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113513307800_R73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1399-543X.2005.00097.x","article-title":"Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.","volume":"6","author":"Saad","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"key\n\t\t\t\t2019041113513307800_R74","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1515\/CCLM.2007.113","article-title":"Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.","volume":"45","author":"Vrbikova","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t2019041113513307800_R75","first-page":"126","article-title":"American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.","volume":"11","author":"American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee","year":"2005","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113513307800_R76","first-page":"1389","article-title":"ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002.","volume":"100","author":"American College of Obstetricians and Gynecologists","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113513307800_R77","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","article-title":"Standards of medical care in diabetes\u20132007","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113513307800_R78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/12\/4546\/9051371\/jcem4546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T10:46:13Z","timestamp":1557053173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/12\/4546\/2596799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1549","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}